|
Volumn 37, Issue 4, 2005, Pages 20-29
|
Evaluating and treating asthma
a,c b |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
GLUCOCORTICOID;
HELIOX;
IMMUNOMODULATING AGENT;
INTERLEUKIN 4 ANTIBODY;
INTERLEUKIN 5 ANTIBODY;
IPRATROPIUM BROMIDE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
MAGNESIUM SULFATE;
NATALIZUMAB;
OMALIZUMAB;
STEROID;
TIOTROPIUM BROMIDE;
TUMOR NECROSIS FACTOR ALPHA ANTAGONIST;
UNCLASSIFIED DRUG;
AIRWAY OBSTRUCTION;
ALLERGIC REACTION;
ARTERIAL GAS;
ARTERIAL OXYGEN SATURATION;
ASTHMA;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DIAGNOSTIC PROCEDURE;
DISEASE EXACERBATION;
DISEASE SEVERITY;
FORCED EXPIRATORY VOLUME;
GAS ANALYSIS;
HOSPITAL ADMISSION;
HOSPITALIZATION;
HUMAN;
HYPOXIA;
LABORATORY TEST;
LUNG AUSCULTATION;
LUNG FUNCTION TEST;
MEDICAL ASSESSMENT;
META ANALYSIS;
METERED DOSE INHALER;
NEBULIZER;
OXYGEN THERAPY;
PATHOGENESIS;
PATIENT CARE;
PHYSICAL EXAMINATION;
REVIEW;
SPUTUM ANALYSIS;
THORAX RADIOGRAPHY;
TREATMENT INDICATION;
WHEEZING;
|
EID: 18844399603
PISSN: 00136654
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (0)
|